Published in Arch Gen Psychiatry on July 01, 1981
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Atypical antipsychotics for people with both schizophrenia and depression. Cochrane Database Syst Rev (2008) 1.47
The early course of schizophrenia and depression*. Eur Arch Psychiatry Clin Neurosci (2005) 1.07
Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. Br J Pharmacol (1995) 0.99
Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology (Berl) (2003) 0.98
Co-occurring depressive symptoms in the older patient with schizophrenia. Drugs Aging (2008) 0.96
Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.92
Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year. BMJ (1989) 0.90
Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich. Eur Arch Psychiatry Clin Neurosci (1990) 0.88
Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms? Eur Arch Psychiatry Clin Neurosci (2005) 0.86
Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data. Eur Arch Psychiatry Clin Neurosci (2005) 0.84
Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat (2014) 0.81
Depressive symptoms in first episode psychosis: a one-year follow-up study. BMC Psychiatry (2013) 0.80
Forms of antipsychotic therapy: improved individual outcomes under personalised treatment of schizophrenia focused on depression. EPMA J (2011) 0.80
Elderly patients with schizophrenia and depression: diagnosis and treatment. Clin Schizophr Relat Psychoses (2011) 0.77
The correlates of the syndrome of depression in schizophrenia. Indian J Psychiatry (1994) 0.76
Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Population based study of fatigue and psychological distress. BMJ (1994) 5.15
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry (1998) 3.26
Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature (2002) 2.59
Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed disconnectivity reappraised. Br J Psychiatry (2000) 2.53
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry (1997) 2.26
Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry (1992) 2.21
A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain (1997) 1.57
Clozapine: progress in treating refractory schizophrenia. BMJ (1993) 1.56
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial I. Course of illness, stability of diagnosis, and the role of a special maintenance clinic. Br J Psychiatry (1985) 1.39
Sputum liquefying agents: a comparative in vitro evaluation. J Lab Clin Med (1969) 1.24
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
Gamma-band electroencephalographic oscillations in a patient with somatic hallucinations. Lancet (1998) 1.20
Severe lithium toxicity with "normal" serum concentrations. Br Med J (1978) 1.18
Influenza infection causing manic psychosis. Br J Psychiatry (1972) 1.15
Life events and maintenance therapy in schizophrenic relapse. Br J Psychiatry (1973) 1.07
Basophil degranulation: a new method of observation and its correlation with skin testing. J Allergy Clin Immunol (1972) 1.06
The left medial temporal region and schizophrenia. A PET study. Brain (1992) 1.05
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients. Br J Psychiatry (1979) 1.03
Effect of central air conditioning and meteorologic factors on indoor spore counts. J Allergy Clin Immunol (1978) 1.02
Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia? Commun Psychopharmacol (1978) 1.02
An evaluation of the effect of nebulized N-acetylcysteine on sputum consistency. J Allergy (1967) 1.02
A comparison of social workers and psychiatrists in evaluating parasuicide. Br J Psychiatry (1979) 1.00
The Camden schizophrenia surveys. II. High prevalence of schizophrenia in an inner London borough and its relationship to socio-demographic factors. Br J Psychiatry (1996) 0.99
Nebulization of N-acetylcysteine combined with a bronchodilator in patients with chronic bronchitis. A controlled study. Dis Chest (1968) 0.98
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer Sci (2008) 0.97
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. III. Relapse postponement or relapse prevention? The implications for long-term outcome. Br J Psychiatry (1985) 0.95
Clinical and physiological evaluation of mucolytic agents nebulized with soproterenol: 10 per cent N-acetylcysteine verus 10 per cent 2-mercaptoethane sulphonate. Thorax (1970) 0.95
Evaluation of changes in sputum consistency with a new instrument. Am Rev Respir Dis (1966) 0.94
Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years. BMJ (1990) 0.93
Depression in schizophrenia: recognition and management in the USA. Schizophr Res (2001) 0.92
Psychosocial factors in the cause and prevention of relapse in schizophrenia. Br Med J (Clin Res Ed) (1983) 0.92
15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet (1984) 0.92
Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem Biophys Res Commun (1995) 0.92
Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neurosci Lett (1996) 0.90
Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year. BMJ (1989) 0.90
Shortening hospital stay for psychiatric care: effect on patients and their families. Br Med J (1979) 0.88
Schizophrenia, neurodevelopment, and disease. The Fifth Biannual Winter Workshop on Schizophrenia, Badgastein, Austria, January 28 to February 3, 1990. Arch Gen Psychiatry (1991) 0.88
EEG spectral analysis in schizophrenia. Br J Psychiatry (1980) 0.88
Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia. Br J Psychiatry (1998) 0.88
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. II. The incidence of compliance problems, side-effects, neurotic symptoms and depression. Br J Psychiatry (1985) 0.88
Effects of brief hospitalization on psychiatric patients' behaviour and social functioning. Acta Psychiatr Scand (1981) 0.87
A one-year survey of mold growth inside twelve homes. Ann Allergy (1976) 0.87
Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics. Exp Brain Res (2006) 0.87
Neuropathological changes in the nucleus basalis in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2012) 0.86
Does short term placebo treatment of chronic schizophrenia produce long term harm? Br Med J (Clin Res Ed) (1986) 0.86
[The scientific status of the theory that parents cause schizophrenia (author's transl)]. Nervenarzt (1979) 0.86
Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
The causality of depression in schizophrenia. Br J Psychiatry (1983) 0.85
Parasuicide. A review of treatment interventions. J Affect Disord (1982) 0.84
DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison. Acta Psychiatr Scand (1981) 0.84
Circulating basophils in normal subjects and in subjects with hay fever. J Allergy Clin Immunol (1976) 0.83
Psychiatric symptoms in self-poisoning patients. Psychol Med (1979) 0.83
Caution and conservatism in the use of a psychiatric day hospital: evidence from a research project that failed. Psychiatry Res (1980) 0.83
Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers. Eur Arch Psychiatry Clin Neurosci (2012) 0.83
Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetes. JAMA (1980) 0.82
Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatr Scand (2002) 0.82
A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis. J Allergy Clin Immunol (1990) 0.82
Clinical change as a function of brief admission to hospital in a controlled study using the present state examination. Br J Psychiatry (1980) 0.82
Pathway and hemispheric differences in the event-related potential (ERP) to monaural stimulation: a comparison of schizophrenic patients with normal controls. Biol Psychiatry (1985) 0.81
Cytomegalovirus and schizophrenia. A test of a viral hypothesis. Br J Psychiatry (1985) 0.81
Comparison between the Brief Psychiatric Rating Scale and the Manchester Scale for the rating of schizophrenic symptoms. Acta Psychiatr Scand (1986) 0.81
No evidence for left superior temporal dysfunction in asymptomatic schizophrenia and bipolar disorder. PET study of verbal fluency. Br J Psychiatry (1999) 0.81
Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia. Acta Psychiatr Scand (1979) 0.80
Low dose maintenance medication for schizophrenia. Br Med J (Clin Res Ed) (1986) 0.80
Dextro-propranolol in schizophrenia. Prog Neuropsychopharmacol (1980) 0.79
Existence of basophil chemotaxis in subjects with hay fever. J Allergy Clin Immunol (1980) 0.79
Schizophrenia and spectral analysis of the visual evoked potential. Br J Psychiatry (1984) 0.79
Increased CSF amino acids and ventricular enlargement in schizophrenia: a preliminary study. Biol Psychiatry (1987) 0.78
Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia. Neuropsychobiology (1998) 0.78
Role of polyamines in the membrane pathology of schizophrenia. A study using fibroblasts from schizophrenic patients and normal controls. Schizophr Res (1994) 0.78
Rinkel injection therapy: a multicenter controlled study. J Allergy Clin Immunol (1981) 0.78
Electroconvulsive therapy for patient with cardiac pacemaker. Br Med J (1979) 0.78
Does propranolol have an antipsychotic effect? A placebo-controlled study in acute schizophrenia. Br J Psychiatry (1986) 0.78
Depression 'revealed' in schizophrenia. Br J Psychiatry (1982) 0.78
Recommendations for the use of residential air-cleaning devices in the treatment of allergic respiratory diseases. J Allergy Clin Immunol (1988) 0.77
The absolute peripheral basophil count. A new and more precise method. J Allergy Clin Immunol (1974) 0.77
Oligodendrocyte density is changed in the basolateral amygdala in schizophrenia but not depression. Schizophr Res (2013) 0.77
The direct basophil degranulation test and the intracutaneous test: a comparison using food extracts. J Allergy Clin Immunol (1975) 0.77
Symptom dimensions in old-age schizophrenics. Relationship to neuropsychological and motor abnormalities. Schizophr Res (1999) 0.77
Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia. Drug Saf (1993) 0.77
Metabolic effects of combination glipizide and human proinsulin treatment in NIDDM. Diabetes Care (1990) 0.76
The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function. Psychopharmacology (Berl) (1987) 0.76
(Des-Tyr)-gamma-endorphin in the treatment of schizophrenia. Psychol Med (1981) 0.76
Parental abnormalities of verbal communication in the transmission of schizophrenia. Psychol Med (1971) 0.76
Depressive disorder due to craniopharyngioma. J R Soc Med (1995) 0.76
Low risk of contrast media-induced acute renal failure in nonazotemic type 2 diabetes mellitus. Kidney Int (1982) 0.76
The platelet polyphosphoinositide system in schizophrenia: the effects of neuroleptic treatment. Biol Psychiatry (1990) 0.76
Evaluation of nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Ann Allergy (1994) 0.76
The concept and efficacy of the treatment of parasuicide. Br J Clin Pharmacol (1983) 0.75
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry (1996) 0.75
The expectorant effect of glyceryl guaiacolate in patients with chronic bronchitis. A controlled in vitro and in vivo study. Chest (1973) 0.75
The third biannual winter workshop on schizophrenia. Schladming, Austria, Jan 26-31, 1986. Arch Gen Psychiatry (1986) 0.75
Phenylacetic acid in CSF and serum in Indian schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.75
Visual evoked potentials in schizophrenia. Intensity effects and hemispheric asymmetry. Br J Psychiatry (1983) 0.75